FI962725A0 - Farmaseuttisia formulaatioita, jotka käsittävät polytioureaa sekä menetelmä niiden käyttämiseksi - Google Patents

Farmaseuttisia formulaatioita, jotka käsittävät polytioureaa sekä menetelmä niiden käyttämiseksi

Info

Publication number
FI962725A0
FI962725A0 FI962725A FI962725A FI962725A0 FI 962725 A0 FI962725 A0 FI 962725A0 FI 962725 A FI962725 A FI 962725A FI 962725 A FI962725 A FI 962725A FI 962725 A0 FI962725 A0 FI 962725A0
Authority
FI
Finland
Prior art keywords
polytiourea
methods
well
pharmaceutical formulations
formulations
Prior art date
Application number
FI962725A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962725A (fi
Inventor
Michael John Mullins
William Arthur Fordyce
William Jack Kruper
Norton Paul Peet
Alan Douglas Cardin
Original Assignee
Merrell Pharma Inc
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc, Dow Chemical Co filed Critical Merrell Pharma Inc
Publication of FI962725A publication Critical patent/FI962725A/fi
Publication of FI962725A0 publication Critical patent/FI962725A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
FI962725A 1994-01-03 1995-01-03 Farmaseuttisia formulaatioita, jotka käsittävät polytioureaa sekä menetelmä niiden käyttämiseksi FI962725A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17658694A 1994-01-03 1994-01-03
PCT/US1995/000118 WO1995018791A1 (en) 1994-01-03 1995-01-03 Pharmaceutical formulations comprising polythiourea and method of use thereof

Publications (2)

Publication Number Publication Date
FI962725A FI962725A (fi) 1995-07-02
FI962725A0 true FI962725A0 (fi) 1996-07-02

Family

ID=22644965

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962725A FI962725A0 (fi) 1994-01-03 1995-01-03 Farmaseuttisia formulaatioita, jotka käsittävät polytioureaa sekä menetelmä niiden käyttämiseksi

Country Status (23)

Country Link
US (1) US6086864A (zh)
EP (1) EP0738261B1 (zh)
KR (1) KR100362343B1 (zh)
CN (1) CN1070180C (zh)
AP (1) AP638A (zh)
AT (1) ATE178595T1 (zh)
AU (1) AU693853B2 (zh)
CA (1) CA2179988C (zh)
CZ (1) CZ197996A3 (zh)
DE (1) DE69508913T2 (zh)
DK (1) DK0738261T3 (zh)
ES (1) ES2133734T3 (zh)
FI (1) FI962725A0 (zh)
GR (1) GR3030521T3 (zh)
HU (1) HUT74694A (zh)
IL (1) IL112174A (zh)
MX (1) MX9602542A (zh)
NO (1) NO306613B1 (zh)
NZ (1) NZ279587A (zh)
OA (1) OA10367A (zh)
TW (1) TW303377B (zh)
WO (1) WO1995018791A1 (zh)
ZA (1) ZA9410408B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6186659B1 (en) * 1998-08-21 2001-02-13 Agilent Technologies Inc. Apparatus and method for mixing a film of fluid
CN105582020B (zh) * 2014-10-21 2019-04-16 浙江大学 一种线形聚硫脲和超支化聚硫脲在制备抗肿瘤药物及抗病毒或抗菌药物中的应用
CN107236128A (zh) * 2017-06-21 2017-10-10 华南理工大学 一种异腈、硫和胺的多组分聚合制备聚硫脲的方法及该聚硫脲的应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE544868A (zh) *
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US2833744A (en) * 1953-08-27 1958-05-06 Ciba Pharm Prod Inc Polyureas and process of preparing same
US2868834A (en) * 1955-02-01 1959-01-13 Ciba Pharm Prod Inc Manufacture of new polythioureas
US3164571A (en) * 1959-12-31 1965-01-05 Union Carbide Corp Polyureas from n-phenyl, phenylene biscarbamyl halide and a diamine
US3528949A (en) * 1968-05-07 1970-09-15 Atlas Chem Ind Polymers from ureas and dihalides
US3978024A (en) * 1973-12-28 1976-08-31 General Electric Company Flame retardant polycarbonate composition
US4328244A (en) * 1980-05-21 1982-05-04 The Dow Chemical Company Novel (((substituted-phenyl)methyl)amino)benzenesulfonic acids and pharmaceutically-acceptable salts thereof
US4349568A (en) * 1980-06-12 1982-09-14 The Dow Chemical Company Sulfur-substituted diphenyl ethers having antiviral activity
US4435394A (en) * 1981-12-17 1984-03-06 Shionogi & Co., Ltd. 3-Sulfonamido-benzophenonimine derivatives useful for treating virus infections
US4471110A (en) * 1982-08-02 1984-09-11 E. I. Dupont De Nemours And Company Polyamide of disulfonated diamine and permselective membrane thereof
US4824916A (en) * 1985-03-15 1989-04-25 The Dow Chemical Company Water-insoluble, crosslinked, sulfonated aromatic polyamide
US4604404A (en) * 1985-04-03 1986-08-05 A. H. Robins Company, Inc. Antiviral sulfonated naphthalene formaldehyde condensation polymers
US4783446A (en) * 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
US4895660A (en) * 1986-07-14 1990-01-23 The Dow Chemical Company Water-soluble aromatic polyamides and polyureas
DE3626309A1 (de) * 1986-08-02 1988-02-18 Stockhausen Chem Fab Gmbh Antivirusmittel
DE3744119A1 (de) * 1987-12-24 1989-07-06 Basf Ag Verwendung von polysulfatierten heparinen
ZA9094B (en) * 1989-01-11 1990-10-31 Merrell Dow Pharma Heparin fraction with anti-hiv activity
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers
US5124149A (en) * 1990-11-07 1992-06-23 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods for biocontrol using fluorescent brighteners
FR2669535A1 (fr) * 1990-11-26 1992-05-29 Medgenix Group Sa Utilisation a titre de medicament de macromolecules polysulfonees.
DE69106493T2 (de) * 1991-02-05 1995-06-29 Merrell Dow Pharma Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen.
US5424063A (en) * 1992-01-09 1995-06-13 The Dow Chemical Company Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process
ATE165345T1 (de) * 1992-02-20 1998-05-15 Merrell Pharma Inc Sulfonsaeurederivate zur behandlung von viruserkrankungen

Also Published As

Publication number Publication date
AP638A (en) 1998-04-14
DE69508913D1 (de) 1999-05-12
IL112174A0 (en) 1995-03-15
HUT74694A (en) 1997-01-28
DK0738261T3 (da) 1999-10-18
CN1138323A (zh) 1996-12-18
ZA9410408B (en) 1995-12-11
EP0738261A1 (en) 1996-10-23
NO306613B1 (no) 1999-11-29
WO1995018791A1 (en) 1995-07-13
OA10367A (en) 2001-11-19
KR100362343B1 (ko) 2003-11-28
ATE178595T1 (de) 1999-04-15
TW303377B (zh) 1997-04-21
GR3030521T3 (en) 1999-10-29
NO962782D0 (no) 1996-07-02
US6086864A (en) 2000-07-11
HU9601813D0 (en) 1996-09-30
CA2179988C (en) 2002-10-29
CZ197996A3 (en) 1996-12-11
NO962782L (no) 1996-09-02
AU693853B2 (en) 1998-07-09
ES2133734T3 (es) 1999-09-16
AP9600842A0 (en) 1996-07-31
IL112174A (en) 1999-05-09
NZ279587A (en) 1997-04-24
FI962725A (fi) 1995-07-02
MX9602542A (es) 1997-05-31
CN1070180C (zh) 2001-08-29
EP0738261B1 (en) 1999-04-07
DE69508913T2 (de) 1999-12-02
AU1675695A (en) 1995-08-01
CA2179988A1 (en) 1995-07-13

Similar Documents

Publication Publication Date Title
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
ID24654A (id) Formulasi farmasi omeprazola
NO965377D0 (no) Indolinonforbindelser samt farmasöytiske preparater inneholdende forbindelsene
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
DE69530325D1 (de) Aerosol-arzneiformulierungen
DE69525148D1 (de) Pharmazeutische formulierung
ITMI913324A0 (it) Agenti farmaceutici
FI973244A0 (fi) Farmaseuttisia valmisteita nenänsisäiseen käyttöönFarmaseuttisia valmisteita nenänsisäiseen käyttöön
NO943044D0 (no) Formuleringer som inneholder hyaluronsyre
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
DK0769965T3 (da) Vandige risperidonformuleringer
NO180584C (no) Bisnaftalimider som inneholder aminosyreavledete linkere, for anvendelse som antikreftmidler, samt farmasöytiske preparater
BR9610396A (pt) Formulação farmacêutica
IS4774A (is) Lyfjafræðilegar samsetningar með D-vítamín hliðstæðum
NO965444D0 (no) Triterpen-derivat samt medikamentell sammensetning omfattende dette
PT868911E (pt) Formulacoes de rapamicina para administracao oral
ID16781A (id) Formulasi-formulasi farmasi
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
TR199501082A2 (tr) Farmasötik formülasyonlar.
ITMI941169A0 (it) Formulazioni farmaceutiche
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973230A (fi) Uusi farmaseuttinen formulaatio
FI962725A0 (fi) Farmaseuttisia formulaatioita, jotka käsittävät polytioureaa sekä menetelmä niiden käyttämiseksi
FI951155A0 (fi) Farmaseuttinen valmiste